307 Results

People

  1. Old
    Old
  2. Ritter
    Ritter
  3. Allison
    Allison
  4. Rudensky
    Rudensky
  5. Gnjatic
    Gnjatic
  6. Wolchok
    Wolchok
  7. Jungbluth
    Jungbluth
  8. O'Reilly
    O'Reilly
  9. Pamer
    Pamer
  10. Yuan
    Yuan

Groups

  1. GSK Faculty (144)
  2. Department of Medicine (131)
  3. Sloan Kettering Institute Faculty (108)
  4. Sloan Kettering Institute Postdocs (90)
  5. Immunology Program Faculty (76)
  6. Hematologic Malignancies, Division of (67)
  7. Center for Hematologic Malignancies (64)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (60)
  9. Solid Tumor Oncology Division (58)
  10. Center for Molecular Imaging and Biotechnology (49)
  1. "cd4+ t lymphocyte"
Formats
  1. Journal Article (288)
  2. Review (10)
  3. Editorial (5)
  4. Research Letter (2)
  5. Conference Paper (1)
  6. Guidelines (1)
Groups
  1. GSK Faculty (144)
  2. Department of Medicine (131)
  3. Sloan Kettering Institute Faculty (108)
  4. Sloan Kettering Institute Postdocs (90)
  5. Immunology Program Faculty (76)
  6. Hematologic Malignancies, Division of (67)

More Groups

People
  1. Lloyd Old (31)
  2. Jedd Wolchok (26)
  3. Gerd Ritter (23)
  4. Alexander Rudensky (21)
  5. James Allison (21)
  6. Sacha Gnjatic (19)

More People

Years
  1. 2025 (12)
  2. 2024 (28)
  3. 2023 (12)
  4. 2022 (13)
  5. 2021 (10)
  6. 2020 (11)

More Years

Publications
  1. Blood (22)
  2. Journal of Immunology (21)
  3. Clinical Cancer Research (15)
  4. Journal of Experimental Medicine (13)
  5. Nature (11)
  6. PLoS ONE (11)

More Publications

Publishers
  1. Nature Publishing Group (40)
  2. American Society of Hematology (30)
  3. American Association for Cancer Research (27)
  4. Elsevier Inc. (22)
  5. The American Association of Immunologists, Inc (21)
  6. Cell Press (18)

More Publishers

Results (307)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma
    Journal Article

    Bhutani, M.; Robinson, M.; Foureau, D.; Atrash, S.; Paul, B.; Guo, F.; Grayson, J. M.; Ivanina-Foureau, A.; Pineda-Roman, M.; Varga, C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Targeting T cells with tetravalent bispecific antibodies for the treatment of graft-versus-host disease
    Journal Article

    Espinosa-Cotton, M.; Hoseini, S. S.; Miranda, I. C.; Herrick, J.; Cheung, N. K. V.
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Fungal symbiont transmitted by free-living mice promotes type 2 immunity
    Journal Article

    Liao, Y.; Gao, I. H.; Kusakabe, T.; Lin, W. Y.; Grier, A.; Pan, X.; Morzhanaeva, O.; Shea, T. P.; Yano, H.; Karo-Atar, D.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Clinical response and pathway-specific correlates following TIGIT–LAG3 blockade in myeloma: The MyCheckpoint randomized clinical trial
    Journal Article

    Richard, S.; Lesokhin, A. M.; Paul, B.; Kaufman, J. L.; Pianko, M.; Biran, N.; Vij, R.; Doxie, D. B.; Azeem, M. I.; Martillo, M.; more...
    Nature Cancer (2024)

    Fulltext@MSK | Save
  • CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
    Journal Article

    Skoulidis, F.; Araujo, H. A.; Do, M. T.; Qian, Y.; Sun, X.; Cobo, A. G.; Le, J. T.; Montesion, M.; Palmer, R.; Jahchan, N.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Systemic immunological changes after yttrium-90 radioembolization: A pilot prospective observational study — Clinical insights
    Journal Article

    Kitsel, Y.; Petre, E. N.; Wong, P.; Sotirchos, V.; Vakiani, E.; Dimopoulos, P. M.; Ganesh, K.; Rousseau, B.; Sofocleous, C. T.
    CardioVascular and Interventional Radiology (2024)

    Fulltext@MSK | Save
  • Tissue-colonizing disseminated tumor cells secrete prostaglandin E2 to promote NK cell dysfunction and evade anti-metastatic immunity
    Journal Article

    Pedde, A. M.; Kim, H.; Donakonda, S.; Baumann, T.; Bayerl, F.; Meiser, P.; Hirschberger, A.; Klement, C.; Grassmann, S.; Öllinger, R.; more...
    Cell Reports (2024)

    Fulltext@MSK | Save
  • A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas
    Review

    de Leval, L.; Gaulard, P.; Dogan, A.
    Blood (2024)

    Fulltext@MSK | Save
  • Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma
    Journal Article

    Gunawardana, J.; Law, S. C.; Sabdia, M. B.; Fennell, É; Hennessy, A.; Leahy, C. I.; Murray, P. G.; Bednarska, K.; Brosda, S.; Trotman, J.; more...
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Intermittent MEK inhibition with GITR costimulation rescues T-cell function for increased efficacy with CTLA-4 blockade in solid tumor models
    Journal Article

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Verma, S.; Mangarin, L. M.; Nevarro, V. E.; Mehanna, N.; Khan, J. F.; Venkatesh, D.; more...
    Cancer Immunology Research (2024)

    Fulltext@MSK | Save